100 related articles for article (PubMed ID: 10555954)
1. Consequences of nucleic acid conformation on the binding of a trinuclear platinum drug.
Kloster MB; Hannis JC; Muddiman DC; Farrell N
Biochemistry; 1999 Nov; 38(45):14731-7. PubMed ID: 10555954
[TBL] [Abstract][Full Text] [Related]
2. DNA modifications by a novel bifunctional trinuclear platinum phase I anticancer agent.
Brabec V; Kaspárková J; Vrána O; Nováková O; Cox JW; Qu Y; Farrell N
Biochemistry; 1999 May; 38(21):6781-90. PubMed ID: 10346899
[TBL] [Abstract][Full Text] [Related]
3. Long range 1,4 and 1,6-interstrand cross-links formed by a trinuclear platinum complex. Minor groove preassociation affects kinetics and mechanism of cross-link formation as well as adduct structure.
Hegmans A; Berners-Price SJ; Davies MS; Thomas DS; Humphreys AS; Farrell N
J Am Chem Soc; 2004 Feb; 126(7):2166-80. PubMed ID: 14971952
[TBL] [Abstract][Full Text] [Related]
4. A comparison of DNA binding profiles of dinuclear platinum compounds with polyamine linkers and the trinuclear platinum phase II clinical agent BBR3464.
McGregor TD; Hegmans A; Kaspárková J; Neplechová K; Nováková O; Penazová H; Vrána O; Brabec V; Farrell N
J Biol Inorg Chem; 2002 Apr; 7(4-5):397-404. PubMed ID: 11941497
[TBL] [Abstract][Full Text] [Related]
5. DNA compaction by mononuclear platinum cancer drug cisplatin and the trisplatinum anticancer agent BBR3464: Differences and similarities.
Banerjee T; Dubey P; Mukhopadhyay R
Biochimie; 2012 Feb; 94(2):494-502. PubMed ID: 21893159
[TBL] [Abstract][Full Text] [Related]
6. Conformation, recognition by high mobility group domain proteins, and nucleotide excision repair of DNA intrastrand cross-links of novel antitumor trinuclear platinum complex BBR3464.
Zehnulova J; Kasparkova J; Farrell N; Brabec V
J Biol Chem; 2001 Jun; 276(25):22191-9. PubMed ID: 11303029
[TBL] [Abstract][Full Text] [Related]
7. DNA interstrand cross-links of an antitumor trinuclear platinum(II) complex: thermodynamic analysis and chemical probing.
Malina J; Farrell NP; Brabec V
Chem Asian J; 2011 Jun; 6(6):1566-74. PubMed ID: 21557487
[TBL] [Abstract][Full Text] [Related]
8. Cooperative effects in long-range 1,4 DNA-DNA interstrand cross-links formed by polynuclear platinum complexes: an unexpected syn orientation of adenine bases outside the binding sites.
Qu Y; Scarsdale NJ; Tran MC; Farrell NP
J Biol Inorg Chem; 2003 Jan; 8(1-2):19-28. PubMed ID: 12459895
[TBL] [Abstract][Full Text] [Related]
9. Compacting effect of BBR3464, a new-generation trisplatinum anticancer agent, on DNA.
Banerjee T; Dubey P; Mukhopadhyay R
Biochimie; 2010 Jul; 92(7):846-51. PubMed ID: 20138107
[TBL] [Abstract][Full Text] [Related]
10. Cellular pharmacology of polynuclear platinum anti-cancer agents.
Roberts JD; Peroutka J; Farrell N
J Inorg Biochem; 1999 Oct; 77(1-2):51-7. PubMed ID: 10626354
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of the membrane interaction of polynuclear platinum anticancer agents. Implications for cellular uptake.
Liu Q; Qu Y; Van Antwerpen R; Farrell N
Biochemistry; 2006 Apr; 45(13):4248-56. PubMed ID: 16566599
[TBL] [Abstract][Full Text] [Related]
12. Comparison of cytotoxicity and cellular accumulation of polynuclear platinum complexes in L1210 murine leukemia cell lines.
Roberts JD; Peroutka J; Beggiolin G; Manzotti C; Piazzoni L; Farrell N
J Inorg Biochem; 1999 Oct; 77(1-2):47-50. PubMed ID: 10626353
[TBL] [Abstract][Full Text] [Related]
13. Differences in the cellular response and signaling pathways of cisplatin and BBR3464 ([[trans-PtCl(NH3)(2)]2mu-(trans-Pt(NH3)(2)(H2N(CH2)(6)-NH2)2)]4+) influenced by copper homeostasis.
Kabolizadeh P; Ryan J; Farrell N
Biochem Pharmacol; 2007 May; 73(9):1270-9. PubMed ID: 17234160
[TBL] [Abstract][Full Text] [Related]
14. Translesion DNA synthesis across double-base lesions derived from cross-links of an antitumor trinuclear platinum compound: primer extension, conformational and thermodynamic studies.
Novakova O; Farrell NP; Brabec V
Metallomics; 2018 Jan; 10(1):132-144. PubMed ID: 29242879
[TBL] [Abstract][Full Text] [Related]
15. DNA interstrand cross-links of the novel antitumor trinuclear platinum complex BBR3464. Conformation, recognition by high mobility group domain proteins, and nucleotide excision repair.
Kasparkova J; Zehnulova J; Farrell N; Brabec V
J Biol Chem; 2002 Dec; 277(50):48076-86. PubMed ID: 12226099
[TBL] [Abstract][Full Text] [Related]
16. DNA binding by antitumor trans-[PtCl2(NH3)(thiazole)]. Protein recognition and nucleotide excision repair of monofunctional adducts.
Kasparkova J; Novakova O; Farrell N; Brabec V
Biochemistry; 2003 Jan; 42(3):792-800. PubMed ID: 12534292
[TBL] [Abstract][Full Text] [Related]
17. Structural consequences of a 3'-->3' DNA interstrand cross-link by a trinuclear platinum complex: unique formation of two such cross-links in a 10-mer duplex.
Qu Y; Tran MC; Farrell NP
J Biol Inorg Chem; 2009 Aug; 14(6):969-77. PubMed ID: 19415349
[TBL] [Abstract][Full Text] [Related]
18. Differential recognition by the tumor suppressor protein p53 of DNA modified by the novel antitumor trinuclear platinum drug BBR3464 and cisplatin.
Kasparkova J; Fojta M; Farrell N; Brabec V
Nucleic Acids Res; 2004; 32(18):5546-52. PubMed ID: 15486204
[TBL] [Abstract][Full Text] [Related]
19. Effect of the geometry of the central coordination sphere in antitumor trinuclear platinum complexes on DNA binding.
Kasparkova J; Vrana O; Farrell N; Brabec V
J Inorg Biochem; 2004 Oct; 98(10):1560-9. PubMed ID: 15458817
[TBL] [Abstract][Full Text] [Related]
20. Walking of antitumor bifunctional trinuclear PtII complex on double-helical DNA.
Malina J; Kasparkova J; Farrell NP; Brabec V
Nucleic Acids Res; 2011 Jan; 39(2):720-8. PubMed ID: 20833634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
